本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NovoCure Limited

16.00
+0.49003.16%
成交量:45.05萬
成交額:713.07萬
市值:18.63億
市盈率:-12.23
高:16.15
開:15.49
低:15.29
收:15.51
52周最高:21.45
52周最低:9.82
股本:1.16億
流通股本:9,642.36萬
量比:0.44
換手率:0.47%
股息:- -
股息率:- -
每股收益(TTM):-1.3082
每股收益(LYR):-1.2221
淨資產收益率:-43.22%
總資產收益率:-9.26%
市淨率:5.51
市盈率(LYR):-13.09

資料載入中...

2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/22

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/18

重要事件披露

Form 8-K - Current report
2024/01/09

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/11

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/28

重要事件披露

Form 8-K - Current report
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/26

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/28

重要事件披露

Form 8-K - Current report